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Abstract
Thiolutin is commonly used as a general inhibitor of transcription in yeast. It has
been used to calculate mRNA decay rates by stopping the transcription and then
determining the relative abundance of individual mRNAs at different times after
inhibition. We report here that thiolutin is also an inhibitor of mRNA degradation,
and thus its use can lead to miscalculations of mRNA half-lives. The inhibition of
mRNA decay seems to affect the mRNA degradation pathway without impeding
poly(A) shortening, given that the decay rate of total poly(A) amount is not reduced
by thiolutin. Moreover, the thiolutin-dependent inhibition of mRNA degradation has
variable effects on different functional groups of genes, suggesting that they use
various degradation pathways for their mRNAs. Copyright  2007 John Wiley &
Sons, Ltd.
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Introduction
The process of eukaryotic gene expression involves
several regulated steps at the mRNA level. mRNA
is transcribed by RNA polymerase II and exported
to the cytoplasm. There, the turnover rate of mRNA
is regulated by different pathways. In yeast, two
main routes for mRNA degradation exist. In both
decay pathways, the degradation of mRNA is
initiated by the shortening of the poly(A) tail at the
3′ end (reviewed in Parker and Song, 2004). Then,
either the cap structure of the 5′ end is removed and
the transcript degraded by a 5′ → 3′ exonuclease
or, alternatively, the mRNA is degraded by a series
of 3′ → 5′ exonucleolytic steps.
The study of mRNA stability in eukaryotic sys-
tems is receiving increasing attention because it
is becoming evident that it is an important reg-
ulatory mechanism for gene expression (Cheadle
et al., 2005; Mata et al., 2005; Pe´rez-Ortı´n et al.,
2007; Sunnerhagen, 2007). There are several dif-
ferent methods of studying mRNA stability in yeast
and other eukaryotes (Parker et al., 1991; Mata
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
et al., 2005). All of them have some drawback (dis-
cussed in Parker et al., 1991; Sunnerhagen, 2007).
The use of antibiotic drugs that inhibit RNA poly-
merase II is one of the preferred methods because
of its simplicity and its application to all kinds
of yeast strains. The most commonly used antibi-
otic is thiolutin (Jime´nez et al.,1973), a metabo-
lite produced by Streptomyces luteoreticuli (Celmer
and Solomon, 1955) that inhibits all yeast RNA
polymerases, mainly at the level of initiation (Tip-
per, 1973). However, it has also been reported to
inhibit elongation in E. coli (Khachatourians and
Tipper, 1974). It is commonly used at concentra-
tions around 3 µg/ml but in some cases use of
higher concentrations has been reported (Michan
et al., 2005; Guan et al., 2006). The appearance of
genomic techniques for the measurement of mRNA
stabilities (Wang et al., 2002; Grigull et al., 2004)
has incorporated the use of thiolutin at the genomic
level. Despite its known effects as an inhibitor of
translation (Jime´nez et al., 1973; Tipper, 1973) and
as an elicitor of stress responses (Adams and Gross,
1991; Grigull et al., 2004), the use of this antibiotic
Copyright  2007 John Wiley & Sons, Ltd.
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is becoming more important in gene expression
studies in yeast.
Here, we report that thiolutin has an inhibitory
effect on mRNA degradation that becomes apparent
at concentrations higher than 3 µg/ml. Because this
effect involves the same process, mRNA stability,
which is the goal of the studies that use thiolutin,
its importance cannot be neglected. We have found
that the apparent half-lives measured in individual
or global mRNA stability studies are probably
longer than the real ones, especially when using
higher concentrations of thiolutin.
Materials and methods
Yeast strains, growth conditions, and sampling
procedure for half-lives determination
The yeast strains BQS252 (MAT a, ura3-52, derived
from FY1679) and Z676 [MAT a, his3, leu2-3,
ura3-52, rpb1::HIS3 transformed with plasmid
RY2522 (rpb1-1, URA3, CEN, AMP )] were used.
Cells were grown in YPD (yeast extract 1%, pep-
tone 2%, glucose 2%) with agitation at 28 ◦C
and recovered by centrifugation at OD600 = 0.5.
Cell samples were taken at different times after
thiolutin addition and were frozen in liquid N2.
RNA samples were purified by phenol extraction as
described (Garcı´a-Martı´nez et al., 2004). For heat-
shock experiments, pre-warmed (65 ◦C) YPD was
added to the culture at 25 ◦C in order to quickly
increase the temperature to 37 ◦C. Then samples
were taken as previously described. Thiolutin was
a gift from Pfizer. Several different batches were
used.
Northern blot analysis
Electrophoresis was done in 1% agarose in 1×
MOPS and 6.4% formaldehyde. The samples were
transferred to a nylon membrane (Hybond N+,
Amersham) by capillarity with 6× SSC overnight
and UV crosslinked. Then the filter was hybridized
for 16 h at 42 ◦C in 50% formamide, 5× SSPE,
5% dextran sulphate, 0.5% SDS, 5× Denhardt’s
solution and salmon sperm DNA 200 µg/ml. DNA
probes for ACT1 and RPL24 were obtained by
PCR. The probes cover the entire ORF and were
labelled by random primer using 33P-dCTP and
Ready-to-Go kit (Amersham). The filters were
washed twice during 10 min at 42 ◦C (2× SSPE
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and 0.1% SDS) and once during 15 min at 65 ◦C
(1× SSPE and 0.1% SDS) and exposed to an
imaging plate (BAS-MP, Fujifilm).
Poly(A) RNA measurement
A dot–blot procedure to estimate the proportion
of poly(A) mRNA in the total RNA was used.
Three different dilutions of total RNA extracted
from each time point were spotted, using a BioGrid
robot (BioRobotics) on a nylon filter. The fil-
ter was hybridized with 32P-5′-labelled poly(dT)
as described previously (Garcı´a-Martı´nez et al.,
2004.) These data were used to calculate the pro-
portion of poly(A) mRNA in each sample.
Macroarray hybridization
cDNA labelling with a (dT)15VN primer, and
hybridization on in-house prepared nylon mem-
brane macroarrays were performed as described
previously (Alberola et al., 2004). In order to mea-
sure the half-life, the intensities were normal-
ized to the sum of all spot intensities and re-
weighted using the poly(A) dot–blot data. Half-
life data for yeast genes obtained in this work are
available at: http://scsie.uv.es/chipsdna/chipsdna-
e.html#datos. Original macroarray data were sub-
mitted to the GEO database, where they have been
assigned Accession Nos GSE7261 and GSE8629.
Results
Apparent mRNA decay rates depend on the
thiolutin concentration used
Thiolutin is commonly used as a transcriptional
inhibitor for mRNA half-life determinations in
yeast (Parker et al., 1991). Many researchers use
3 µg/ml as the working concentration (Herrick
et al., 1990; Grigull et al., 2004) but the use
of higher concentrations has also been reported
(Michan et al., 2005; Guan et al., 2006). In order
to test the working concentration for our experi-
ments we tried several different ones in the range
1–30 µg/ml. We observed that addition of thio-
lutin at concentrations 3 µg/ml or higher stopped
growth for several hours in an S288c back-
ground strain (not shown). Next, we used 3, 6,
10 and 18 µg/ml thiolutin for decay rate calcu-
lation (Figure 1). As shown in Figure 1, 3 µg/ml
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Figure 1. Effect of different thiolutin concentrations in the estimation of apparent mRNA half-lives. (A) Northern blot
hybridized with probes for ACT1 and RPL24 genes of samples taken at different times after the addition of increasing
amounts of thiolutin. (B) Calculation of the half-life of RPL24 mRNA for the different thiolutin concentrations shown in (A).
(C) Calculation of the half-life of ACT1 mRNA for the different thiolutin concentrations shown in (A). The experiments were
done in duplicate and the error bars represent the standard deviation between replicates. All samples were normalized
using ethidium bromide staining of the 25S rRNA
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of thiolutin generates estimations of mRNA half-
lives that are in agreement with those previously
known (31–77 min for ACT1 and 11–24 min
for RPL24 ; Santiago et al., 1986; Herrick et al.,
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1990; Wang et al., 2002). However, the addition
of higher concentrations of thiolutin leads to the
estimation of apparently longer mRNA half-lives
in a concentration-dependent manner. This effect
Copyright  2007 John Wiley & Sons, Ltd. Yeast 2007; 24: 000–000.
DOI: 10.1002/yea
UN
CO
RR
EC
TE
D P
RO
OF
S
4 V. Pelechano and J. E. Pe´rez-Ortı´n
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
depends on the strain used. For instance, W303
strain requires 8 µg/ml to obtain results equivalent
to those observed using 3 µg/ml in the S288c back-
ground (L. Romero-Santacreu and P.M. Alepuz,
personal communication). Because it seems unrea-
sonable that transcription inhibition decreases with
the increase in thiolutin concentration, we conjec-
tured that another cellular process was affected.
The simplest explanation would be that mRNA
degradation was also inhibited by thiolutin.
Thiolutin inhibits mRNA degradation without
affecting global poly(A) decay
To test the hypothesis that thiolutin inhibits mRNA
degradation, we used the thermo-sensitive mutant
of the large RNA pol II subunit rpb1-1, which
is also commonly used for mRNA decay deter-
minations (Parker et al., 1991; Wang et al., 2002;
Grigull et al., 2004). As shown in Figure 2, the
transcription stop due to a heat shock provokes
a continuous decrease in the mRNA amount for
ACT1 and RPL24 mRNAs that allows for the
measurement of their half-lives. RPL24 and ACT1
apparent half-lives calculated from this experiment
were 14 and 34 min in the absence of thiolutin.
However, if thiolutin was added to 20 µg/ml at the
same time as the heat-shock, the mRNA amounts
remained stable, indicating that, although RNA pol
II transcription was stopped by the RNA poly-
merase inactivation, the mRNA degradation path-
ways were affected by thiolutin.
In yeast, mRNA degradation pathways begin
with the shortening of the 3′ poly(A) tail (Parker
and Song, 2004). We wanted to determine whether
the total amount of poly(A) tail was affected dur-
ing the treatment. To address this point, we made a
dot–blot analysis of the amount of total poly(A) in
the different samples taken after thiolutin addition
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(Figure 3). We observed that the poly(A) amount
decayed at all thiolutin concentrations used. In fact,
the decay was somewhat faster for higher thio-
lutin concentrations. Therefore, we concluded that
thiolutin-dependent block of mRNA degradation
was not due to an overall inhibition of poly(A)
shortening.
Thiolutin affects mRNA decay for all genes, but
it differentiates between genes according to
their function
In order to calculate the mRNA decay rates for
all yeast genes, we used a similar method to
that described by Wang et al. (2002) and Grigull
et al. (2004). Samples from cells were taken at
0, 10, 20, 30 and 45 min after the addition of
3 µg/ml thiolutin. cDNA was labelled with 33P-
dCTP by oligo-(dT)15VN priming and hybridized
Figure 3. Total poly(A) quantisation after thiolutin
treatments. Quantization of the spot intensities from a
dot–blot made with total RNA from the samples used in
Figure 1 hybridized with 32P-labelled-poly(T). Intensity at
time zero (before thiolutin addition) is arbitrarily taken as 1
Figure 2. Inhibition of mRNA degradation by thiolutin. Northern blot of samples taken at different times after heat-shock
at 37 ◦C of the rpb1-1 strain with or without addition of thiolutin to 20 µg/ml. The calculated half-lives are shown on
the right of each series. n.a. indicates that the amount of mRNA increases during the experiment and, therefore, half-life
calculation is not applicable. All samples were normalized using ethidium bromide staining of the 25S rRNA
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to nylon macroarrays as described (Alberola et al.,
2004). The use of such an oligonucleotide, which
only primes at the beginning of the poly(A) tail,
guarantees that the labelling is only dependent
on the number of poly(A) molecules and not on
their length. Normalization of the array signals
was done using global poly(A) decay. The decay
rates data obtained were reasonably similar to those
obtained by Grigull et al. (2004) using thiolutin.
The correlation coefficient between the degradation
constants (k ) is 0.40, which is similar to the
correlation observed between the rpb1-1 data of
Grigull et al. (2004) and Wang et al. (2002), viz.
0.42.
In order to ensure that increases in thiolutin
concentration affected the apparent half-life of
all genes, we treated another yeast culture with
10 µg/ml thiolutin and calculated the apparent
half-lives. A comparison of the results obtained
using the two thiolutin concentrations is shown in
Figure 4. The general trend of yeast mRNAs is
to increase their apparent half-life, which demon-
strates that the thiolutin-dependent effect of mRNA
degradation pathways is general. We used the
northern blot data from ACT1 (which remains
in the same relative position in the two distribu-
tions) in order to normalize the two sets of data.
However, when analysing the bias of functionally-
related groups of genes, it was evident that some
groups were more affected (apparent half-lives
more increased) that the average, e.g. ribosomal
proteins and RiBi regulon (Jorgensen et al., 2004).
On the other hand, some groups were less affected
than the average, e.g. sulphur amino acid transport,
siderophore transport, sulphate assimilation and
iron transport. The functional categories present in
the second class suggested that the transcription
of those genes may be induced in response to the
weak stress induced by low concentrations of thi-
olutin (see Grigull et al., 2004), but that at higher
drug concentrations the transcriptional block was
too fast to allow gene induction.
Discussion
The determination of mRNA stability is of increas-
ing relevance because mRNA turnover is emerg-
ing as an important factor in the regulation of
gene expression in eukaryotic cells (Mata et al.,
2005; Pe´rez-Ortı´n et al., 2007). In yeast, the use
Figure 4. Genomic analysis of thiolutin effect on mRNA
decay. Histogram of the apparent degradation constants
[k = (−1/t1/2)] using different thiolutin concentrations.
ACT1 half-life calculated from Northern blot data (Figure 1)
was used to normalize the results. This gene remained in
the same relative position (marked with an arrow) to the
distribution in both cases. The experiments were done in
duplicate being the Pearson correlation coefficients between
replicates of 0.9 or greater
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of antibiotics to inhibit RNA polymerase II tran-
scription followed by determination of the rela-
tive abundance of the mRNAs is a useful method
to evaluate half-lives because it is applicable to
any strain. The antifungal thiolutin (Jime´nez et al.,
1973) is the most common drug used for this pur-
pose. It is thought that thiolutin inhibits all nuclear
RNA polymerases by directly interacting with the
enzymes and does not inhibit elongating RNA
polymerases (Tipper, 1973).
The thiolutin concentration used for mRNA sta-
bility experiments in yeast varies in the range
3–25 µg/ml (Adams and Gross, 1991; Grigull
et al., 2004; Guan et al., 2006; Minvielle-Sebastia
et al., 1991; Herrick et al., 1990; Parker et al.,
1991; Michan et al., 2005). In general, it is
assumed that any concentration above 3 µg/ml
has, essentially, the same effect (Herrick et al.,
1991). However, in the course of our work we
have noted that the apparent half-lives of several
mRNAs vary depending the particular concentra-
tion used (Figure 1). Concentrations below (not
shown) and above 3 µg/ml lead to mRNA half-life
estimates that are longer than expected. Problems
with mRNA half-life determination have been pre-
viously noted by others (Brendolise et al., 2002).
Whereas for lower concentrations this result can
be easily explained because of incomplete inhi-
bition of the transcriptional activity, the explana-
tion for the effect of higher concentrations is not
Copyright  2007 John Wiley & Sons, Ltd. Yeast 2007; 24: 000–000.
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straightforward. We hypothesized that this effect
could be the consequence of an additional inhibi-
tion of mRNA degradation at higher concentrations
(Figure 5). In fact, thiolutin is known to inhibit
other biological processes, such as translation and
rRNA processing, when used at 20 µg/ml (Jime´nez
et al., 1971). The overlapping effect of increas-
ing transcriptional inhibition from low thiolutin
concentrations and the increasing mRNA degrada-
tion from higher concentrations would produce a
curve with a minimum for half-life determination
(Figure 5). According to our data and those from
other groups (Guan et al., 2006), the result depends
on the particular strain background used.
We have provided experimental evidence for
our hypothesis by using a conditional RNA poly-
merase II mutant strain (Figure 2). As transcription
is blocked by temperature inactivation of Rpb1p in
this strain, the addition of thiolutin cannot have
Figure 5. A model for thiolutin actions in yeast cells.
(A) Thiolutin inhibition of transcription (black) and of
mRNA degradation (grey) provokes a complex response for
the measured mRNA half-life. The solid curve represents the
approximate effect of transcription and mRNA degradation
and the dotted line represents for the predicted sum of
effects on apparent half-life. (B) Blocking of transcription
occurs at the level of initiation (Tipper, 1973) at any
concentration whereas blocking of mRNA degradation
occurs only at high concentration (this work)
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additional effects on transcriptional shut-off if the
inactivation is complete. Alternatively, if Rpb1p
inactivation were not complete, the shut-off caused
by thiolutin would reduce the apparent half-life.
Because the relatively high concentration of thio-
lutin used (20 µg/ml) produces an increase of the
mRNA half-lives, the simpler explanation is that
concentration affects the mRNA degradation path-
ways. It is interesting to mention that a similar
experiment was done by Guan et al. (2006) but
using 10 µg/ml of thiolutin. They found, however,
that thiolutin did not change the apparent half-
life measured. Because the addition of 10 µg/ml
had an effect on the mRNA half-life determina-
tion (Figure 1) in our hands, we think that the
discrepancy could be due to variations in the activ-
ity of different thiolutin batches. In fact, Guan
et al. (2006) found that the W303 background
requires 2.5 times (25 µg/ml) higher concentration
of thiolutin than for S288c (10 µg/ml) to com-
pletely inhibit transcription. This result is in accor-
dance with our observation that the W303 strain
required 8 instead of 3 µg/ml (2.67 times higher)
to obtain the minimum apparent half-life. We also
have observed that different thiolutin batches have
varying biological activities. These differences are
likely due to the fact that thiolutin preparations con-
tain important amounts of contaminants — up to
20% in some batches, as determined by mass spec-
trometry (not shown). This would explain the use
of higher thiolutin concentrations by other authors
(Guan et al., 2006; Michan et al., 2005).
In yeast, mRNA degradation is usually started by
poly(A) tail shortening (Parker and Song, 2004).
We have found that, whereas northern analy-
sis shows that individual mRNAs are stabilized
by high thiolutin concentrations (Figures 1, 2) the
global poly(A) amount for yeast mRNAs decays
at those concentrations (Figure 3). Our results are
in agreement with the previous results reported by
Minvielle-Sebastia et al. (1991) and Herrich et al.
(1990), who showed that blocking transcription
either by temperature shift of an rpb1-1 mutant or
by addition of thiolutin in a wt strain did not block
poly(A) shortening. Northern blots and macroar-
ray experiments detect a slower mRNA degrada-
tion in the presence of high thiolutin concentration;
hence, they are not sensitive to the change in pro-
portion between polyadenylated and deadenylated
pools of the mRNAs. Although we cannot discard
the suggestion that individual mRNA species can
Copyright  2007 John Wiley & Sons, Ltd. Yeast 2007; 24: 000–000.
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have different behaviours, we suggest that inhibi-
tion of mRNA degradation occurs after deadeny-
lation. It has been shown that thiolutin induces
some stress in yeast cells (Grigull et al., 2004) and
that stress induces mRNA stabilization (reviewed
in Bond, 2006). However, the stress stabilization
of mRNA occurs by inhibition of deadenylation
(Hilgers et al., 2006), hence the effect of thiolutin
cannot be an indirect consequence of the stress.
Thiolutin also has an inhibitory effect on transla-
tion at high concentrations (Jime´nez et al., 1973)
and it is known that inhibition of translation blocks
mRNA degradation at the level of decapping, with-
out inhibiting deadenlylation (Beelman and Parker,
1994). Thus, it is possible that the inhibition of
mRNA degradation observed by addition of high
thiolutin concentrations is due to its effect on trans-
lation.
Our study shows that the effect of thiolutin
on mRNA degradation is at the genomic level.
We found that 3533 genes of the 4222 analysed
had an increase in their apparent mRNA half-life
(Figure 4). This effect was, however, not identical
for all of them. For some groups related to sulphur,
sulphate and iron metabolism, the deviation from
the average behaviour came, probably, from the
physiological stress caused by this drug (Grigull
et al., 2004). The apparent half-lives of the mRNAs
in other groups, mainly those related to translation,
are more affected by thiolutin. Because it is known
that different mRNA degradation pathways act
in parallel (Parker and Song, 2004), this would
indicate that, for those mRNAs, the pathway(s)
inhibited by thiolutin have an increased importance
with regard to the average of yeast genes.
The use of thiolutin, and other drugs, to stop
transcription has some drawbacks. It was already
known that these drugs can cause stress responses
in yeast which precludes their use for mRNA sta-
bility determinations for stress-responsive genes
(Grigull et al., 2004). Moreover, we have shown
here that thiolutin has another unavoidable draw-
back. The sum of its inhibitory effects on RNA
polymerase II and mRNA degradation led to poor
estimates of mRNA half-lives (Figure 5). If the
concentration used is too low (<2–3 µg/ml for
the S288c background), transcription is not fully
stopped. If the concentration used is too high
(>3 µg/ml), the inhibitory effects of mRNA degra-
dation are seen. In any case, a longer half-life
than the actual one will be measured. This effect
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was probably the reason why mRNA half-lives
were slightly longer when measured by thiolutin
treatment than by other techniques (Herrick et al.,
1990). We recommend to check which is the right
concentration of thiolutin for each strain to avoid
secondary effects.
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